The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R/S)-3-[3-(Tert-butylamino)-2-hydroxypropoxy]-5-methyl-9Hxanthen-9-one hydrochloride ID: ALA4128231
PubChem CID: 145963046
Max Phase: Preclinical
Molecular Formula: C21H26ClNO4
Molecular Weight: 355.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cccc2c(=O)c3ccc(OCC(O)CNC(C)(C)C)cc3oc12.Cl
Standard InChI: InChI=1S/C21H25NO4.ClH/c1-13-6-5-7-17-19(24)16-9-8-15(10-18(16)26-20(13)17)25-12-14(23)11-22-21(2,3)4;/h5-10,14,22-23H,11-12H2,1-4H3;1H
Standard InChI Key: XSRKCZPYMWRERC-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
21.8336 -8.7453 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13.3244 -7.4781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0389 -7.8906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7534 -7.4781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4679 -7.8906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4679 -8.7156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7534 -9.1282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0389 -8.7156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3244 -9.1282 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.6099 -8.7156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8955 -9.1282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1810 -8.7156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1810 -7.8906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8955 -7.4781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6099 -7.8906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3244 -6.6532 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.8955 -9.9532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1824 -9.1282 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.8968 -8.7156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6113 -9.1282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3258 -8.7156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6113 -9.9532 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.0402 -9.1282 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7547 -8.7156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4692 -9.1282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7547 -7.8906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4667 -8.2959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
3 8 2 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
2 15 1 0
2 16 2 0
11 17 1 0
19 20 1 0
20 21 1 0
18 19 1 0
20 22 1 0
21 23 1 0
6 18 1 0
23 24 1 0
24 25 1 0
24 26 1 0
24 27 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 355.43Molecular Weight (Monoisotopic): 355.1784AlogP: 3.38#Rotatable Bonds: 5Polar Surface Area: 71.70Molecular Species: BASEHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.66CX LogP: 3.37CX LogD: 1.16Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.69Np Likeness Score: -0.22
References 1. Kubacka M, Szkaradek N, Mogilski S, Pańczyk K, Siwek A, Gryboś A, Filipek B, Żmudzki P, Marona H, Waszkielewicz AM.. (2018) Design, synthesis and cardiovascular evaluation of some aminoisopropanoloxy derivatives of xanthone., 26 (13): [PMID:29706529 ] [10.1016/j.bmc.2018.04.038 ]